ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Ann Thorac Surg 2010;90:703-705. doi:10.1016/j.athoracsur.2010.05.012
© 2010 The Society of Thoracic Surgeons

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Alexander Kulik
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kulik, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kulik, A.
Related Collections
Right arrow Valve disease
Right arrowRelated Article


Editorial

Aortic Root Enlargement: Worth the Effort?

Alexander Kulik, MD, MPH*

Division of Cardiothoracic Surgery, Lynn Heart Institute, Boca Raton Community Hospital, Boca Raton, Florida

* Address correspondence to Dr Kulik, Lynn Heart Institute, Boca Raton Community Hospital, 801 Meadows Rd, Ste 104, Boca Raton, FL 33486 (Email: alex_kulik@yahoo.com).

In patients with advanced aortic valve disease, the goals of aortic valve replacement (AVR) are to reduce pressure and volume overload on the left ventricle, relieve symptoms, and improve long-term survival. Ideally, transprosthetic pressure gradients after surgery should be minimal. Despite normally functioning prostheses, however, high pressure gradients are occasionally seen after surgery, particularly in patients who have received small-sized prosthetic valves. This results in persistent postoperative left ventricular outflow tract obstruction, a condition termed prosthesis–patient mismatch (PPM). First described by Rahimtoola [1] in 1978, PPM is described as an "effective prosthetic valve area, after insertion into the patient, that is less than that of a normal valve." Pibarot and Dumesnil [2] have since defined aortic PPM as a prosthetic valve effective orifice area (EOA) indexed to body surface area of less than 0.85 cm2/m2.

Considerable controversy exists in literature regarding the significance of PPM and its impact on postoperative outcomes after valve replacement. Although some studies have suggested that there is no risk associated with PPM [3–5], others have demonstrated PPM to be a strong and independent risk factor for adverse events after AVR [2, 6–9]. Several groups have shown that PPM is associated with reduced early and late survival after AVR [2, 6, 7]. With residual postoperative gradients, PPM has also been linked to reduced left ventricular mass regression after surgery [8], as well as lower functional class and exercise tolerance [9]. Mismatch after mitral replacement has also been shown to have a detrimental impact on postoperative outcomes. Defined as an indexed EOA of less than 1.2 cm2/m2, mitral PPM is associated with persistent pulmonary hypertension, congestive heart failure, and reduced survival after surgery [10].

The EOA of . . . [Full Text of this Article]


Related Article

Strategy of Aortic Root Enlargement in Patients Undergoing Aortic and Mitral Valve Replacement
Qianjin Zhong, Yingbin Xiao, Jinjin Chen, and Ruiyan Ma
Ann. Thorac. Surg. 2010 90: 782-787. [Abstract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2010 by The Society of Thoracic Surgeons.